Rivaroxaban in patients with abdominal aortic aneurysm and high-sensitivity C-reactive protein elevation (BANBOO): study protocol for a randomized, controlled trial

BACKGROUND: Abdominal aortic aneurysm (AAA) is a fatal disease due to the tendency to rupture. The drug treatment for small AAA without surgical indications has been controversial. Previous studies showed that high-sensitivity C-reactive protein (hs-CRP) had become a potential biomarker of the disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jingyuan, Ma, Sicong, Jia, Xiu, Bu, Yingzhen, Zhou, Tienan, Zhang, Lei, Qiu, Miaohan, Wang, Xiaozeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280923/
https://www.ncbi.nlm.nih.gov/pubmed/37337298
http://dx.doi.org/10.1186/s13063-023-07461-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280923/
https://www.ncbi.nlm.nih.gov/pubmed/37337298
http://dx.doi.org/10.1186/s13063-023-07461-3

Ejemplares similares